You have 9 free searches left this month | for more free features.

13-229

Showing 1 - 25 of 4,889

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Subject Trial in Shanghai (3D229, Placebo)

Completed
  • Healthy Subject
  • Shanghai, Hongkou District, China
    Shanghai General hospital
Jun 20, 2022

Sickle Cell Disease Trial in New York (Plerixafor)

Recruiting
  • Sickle Cell Disease
  • New York, New York
  • +1 more
Mar 21, 2022

Papulopustular Rosacea Trial in United States (FMX103 1.5%)

Completed
  • Papulopustular Rosacea
  • FMX103 1.5%
  • Glendale, Arizona
  • +78 more
Jan 13, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Glargine)

Completed
  • Type 2 Diabetes
  • Blacktown, New South Wales, Australia
  • +66 more
Dec 12, 2022

Signs and Symptoms, Digestive Trial in Valinhos (Probiatop, Placebo)

Recruiting
  • Signs and Symptoms, Digestive
  • Valinhos, São Paulo, Brazil
    A2Z Clinical Centro Avancado de Pesquisa Clinica Eireli
Oct 31, 2022

Psoriasis Trial in Worldwide (Apremilast, Placebo)

Completed
  • Psoriasis
  • Birmingham, Alabama
  • +51 more
Nov 17, 2022

Outcomes in Tuberculous Patients in Sohag Governorate

Recruiting
  • Tuberculosis
  • sputum analysis
  • lymph node biobsy
  • Sohag, Egypt
    Sohag university Hospital
Nov 15, 2023

Bile cfDNA of Resectable Biliary Tract Carcinomas

Recruiting
  • This Study Aims to Reveal the Effectiveness, Accuracy, and Feasibility in Bile
  • Next generation sequencing
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Mar 13, 2023

Prader-Willi Syndrome, Excessive Daytime Sleepiness, Hyperphagia Trial in Brooklyn (Sham Light, Bright Light Therapy)

Not yet recruiting
  • Prader-Willi Syndrome
  • +5 more
  • Sham Light
  • Bright Light Therapy
  • Brooklyn, New York
    Maimonides Medical Center
Jul 2, 2023

HIV Trial (Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg)

Completed
  • HIV Infections
  • Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg
  • (no location specified)
May 11, 2022

Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

Recruiting
  • Leukemia
  • +2 more
  • applying of FLU+CY post-HSCT
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Nov 23, 2023

Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome Trial (NS-229, Placebo)

Not yet recruiting
  • Eosinophilic Granulomatosis With Polyangiitis
  • Churg-Strauss Syndrome
  • (no location specified)
Sep 14, 2023

Opioid Dependence, Acute Opioid Withdrawal Syndrome Trial in United States (Lofexidine HCl, Placebo, Open Label Lofexidine HCL)

Completed
  • Opioid Dependence
  • Acute Opioid Withdrawal Syndrome
  • Lofexidine HCl
  • +2 more
  • Clovis, California
  • +17 more
Mar 11, 2022

Patients Diagnosed With NSAID Sensitivity in Thailand

Completed
  • Aspirin Sensitivity
  • +7 more
  • aspirin, NSAIDs, paracetamol
  • Bangkok, Thailand
    Faculty of Medicine, Chulalongkorn University
Feb 8, 2022

Colombian Orinoquia: A Retrospective Cohort Trial 2010-2022.

Not yet recruiting
  • Hospital Mortality
  • Risk factor
  • (no location specified)
Feb 12, 2023

Opioid Prescribing Trial in Ann Arbor (Academic detailing)

Not yet recruiting
  • Opioid Prescribing
  • Academic detailing
  • Ann Arbor, Michigan
    University of Michigan
Nov 8, 2023

Prone Position, Acute Respiratory Distress Syndrome Trial in Rome (supine position, prone position)

Not yet recruiting
  • Prone Position
  • Acute Respiratory Distress Syndrome
  • supine position
  • prone position
  • Rome, Italy
    Giorgio Conti
Aug 28, 2023

Chronic Kidney Diseases, Heart Attack, Stroke, Ischemic Trial in Little Rock (Ticagrelor 90mg, Clopidogrel 75mg, Aspirin 81 mg)

Completed
  • Chronic Kidney Diseases
  • +2 more
  • Ticagrelor 90mg
  • +2 more
  • Little Rock, Arkansas
  • +1 more
Dec 8, 2022

Healthy Trial in Tempe (BBP-711, Placebo)

Completed
  • Healthy
  • Tempe, Arizona
    Celerion
Mar 18, 2022

Congenital Cytomegalovirus Infection Trial in United States (Valganciclovir)

Active, not recruiting
  • Congenital Cytomegalovirus Infection
  • Birmingham, Alabama
  • +8 more
Aug 18, 2022

Plasma Von Willebrand Factor Antigen to A Disintegrin-like and

Not yet recruiting
  • Acute on Chronic Liver Failure
    • New Delhi, Delhi, India
      Institute of Liver & Biliary Sciences.
    Sep 28, 2023

    Ulcerative Colitis Trial in Ukraine, United States (NX-13 250mg IR, NX-13 500mg IR, NX-13 500mg MR)

    Completed
    • Ulcerative Colitis
    • NX-13 250mg IR
    • +3 more
    • Huntsville, Alabama
    • +30 more
    Jan 6, 2023

    Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance

    Recruiting
    • Prostate Adenocarcinoma
    • Prostate Cancer
    • Hyperpolarized Carbon C 13 Pyruvate
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Oct 3, 2022

    HIV, Hypertension Trial in Kampala (Integrated HIV/HTN care model)

    Active, not recruiting
    • HIV
    • Hypertension
    • Integrated HIV/HTN care model
    • Kampala, Central Region, Uganda
      Infectious Diseases Research Collaboration
    Nov 1, 2022

    Hemophilia A Trial in Worldwide (Emicizumab)

    Completed
    • Hemophilia A
    • Sacramento, California
    • +16 more
    Dec 13, 2022